Kimberly-Clark Corporation

🇺🇸New York Stock Exchange
Back to all articles
Kimberly-Clark Corporation stock analysis KMB overview
Slightly Bullish +15

Kimberly-Clark Corporation (NASDAQ:KMB) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

📈 Kimberly-Clark reported quarterly EPS of $1.97, beating the $1.93 consensus estimate, with revenue reaching $4.16 billion.

💰 The company declared a quarterly dividend of $1.28 per share, resulting in an annualized yield of approximately 5.1%.

📊 Analysts maintain a consensus 'Hold' rating with an average 12-month price target of roughly $115.43.

🔍 Piper Sandler upgraded the stock to 'overweight' and raised its price target from $115.00 to $121.00.

⚠️ Barclays cut its price objective to $99.00 and Wells Fargo lowered its target to $100.00 with neutral ratings.

🏦 Institutional ownership stands at 76.29%, with Vanguard, State Street, and Charles Schwab increasing holdings in Q4.

📉 Insider selling occurred as Katy Chen and VP Andrew Scribner sold shares to cover tax withholding obligations.

💵 The stock trades at a P/E ratio of 15.78 with a market capitalization of $33.36 billion.

📉 Kimberly-Clark was excluded from MarketBeat's list of five stocks top analysts are currently recommending for buying.

Bullish Signals
  • Kimberly-Clark beat earnings expectations with EPS of $1.97 versus the expected $1.93 and revenue of $4.16 billion versus $4.09 billion.
  • The company offers a high dividend yield of approximately 5.1% based on a quarterly payout of $1.28 per share.
  • Piper Sandler upgraded Kimberly-Clark to an 'overweight' rating and increased its price target from $115.00 to $121.00.
  • Major institutional investors including Vanguard Group, State Street Corp, and Charles Schwab increased their positions in the fourth quarter.
  • The company reported a strong return on equity of 152.79% and a net margin of 12.80%.
Risk Factors
  • Barclys cut its price objective for Kimberly-Clark from $105.00 to $99.00 with an 'equal weight' rating.
  • Wells Fargo decreased its price target from $110.00 to $100.00 and assigned an 'equal weight' rating.
  • Zacks Research downgraded Kimberly-Clark from a 'strong-buy' rating to a 'hold' rating.
  • Corporate insiders sold over $689,000 worth of shares in the last 90 days to cover tax withholding obligations.
  • The stock is currently trading below its average 12-month price target of approximately $115.43.
Full Analysis
Kimberly-Clark Corporation (NASDAQ:KMB) reported better-than-expected quarterly results, posting earnings per share of $1.97 against the consensus estimate of $1.93 and revenue of $4.16 billion versus $4.09 billion expected. Revenue grew 2.7% year over year, while the company declared a quarterly dividend of $1.28 per share, implying an annualized payout of $5.12 and a yield of approximately 5.1%. The stock traded around $100.50 during the session. Wall Street analysts maintain a consensus 'Hold' rating for Kimberly-Clark based on reports from 16 covering analysts, with four buy ratings, eleven hold ratings, and one sell rating. The average 12-month price target among these brokerages is approximately $115.43. Recent analyst actions include Piper Sandler boosting its target to $121.00 with an 'overweight' rating, while Zacks Research cut the stock to a 'hold', and Barclays and Wells Fargo lowered their price objectives. Financial metrics show Kimberly-Clark has a market capitalization of $33.36 billion, a P/E ratio of 15.78, and a debt-to-equity ratio of 3.38. Institutional ownership remains strong at 76.29%, with major holders like Vanguard Group, State Street Corp, and Charles Schwab increasing their positions in the fourth quarter. However, insider activity saw Katy Chen and VP Andrew Scribner sell shares totaling over $1 million combined to cover tax withholding obligations. The article concludes that while Kimberly-Clark is a solid dividend stock, it was not included in MarketBeat's list of five stocks top analysts are currently recommending for purchase. The company continues to operate as a multinational manufacturer of personal care and consumer tissue products with brands like Kleenex and Huggies.